Mark Tiffany, MD
Anesthesiology · Tucson, AZNPI 1407964737
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,203 of the $6,568 with a category attached, or 79.2%. 31 manufacturers reported payments, led by Boston Scientific at 38.8% of the total. Reporting peaked in 2023 at $2,549 and has fallen 96.1% since, to $98 in 2025. Among anesthesiology clinicians in AZ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 186 payments — averaging $35.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$3K
- Medtronic$1K
- Forte Bio-pharma LLC$448
- Abbott$357
- Collegium Pharmaceutical, Inc.$353
- Scilex Pharmaceuticals Inc.$261
- plus $1K from 25 others
What the payments were for
- Travel & lodging$1,36621%
- Food & beverage$5,20379%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 46 | $2,552 |
| Medtronic(2 entities) | 8 | $1,172 |
| Forte Bio-pharma LLC | 4 | $448 |
| Abbott | 18 | $357 |
| Collegium Pharmaceutical, Inc. | 27 | $353 |
| Scilex Pharmaceuticals Inc. | 19 | $261 |
| GRT US Holding, Inc. | 5 | $193 |
| Nevro Corp. | 2 | $182 |
| SPR Therapeutics, Inc | 1 | $137 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 8 | $112 |
| Nalu Medical, Inc. | 2 | $104 |
| AbbVie(2 entities) | 6 | $89 |
| Indivior Inc. | 5 | $85 |
| Biodelivery Sciences International, Inc. | 6 | $80 |
| Assertio Therapeutics, Inc. | 3 | $40 |
| Bioventus LLC | 2 | $38 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $37 |
| MDD US Operations, LLC | 3 | $37 |
| Pfizer | 2 | $32 |
| Sentynl Therapeutics, Inc. | 2 | $30 |
| Biohaven Pharmaceuticals, Inc. | 2 | $30 |
| Arbor Pharmaceuticals, Inc. | 2 | $27 |
| Si-bone, Inc. | 1 | $26 |
| Pacira Therapeutics, Inc. | 1 | $25 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $25 |
| Zyla Life Sciences, Inc. | 2 | $23 |
| Amgen | 1 | $17 |
| Redhill Biopharma Inc. | 1 | $16 |
| AstraZeneca | 1 | $13 |
| IBSA Pharma Inc. | 1 | $13 |
| Orexo US, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,568 in reported general payments places this provider in the 95th percentile of 1,166 anesthesiology providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine | 64 | $14,371 |
| BelbucaBuprenorphine Hcl | 17 | $11,312 |
| Xtampza ErOxycodone Myristate | 14 | $5,630 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 102 | $2,943 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 86 | $2,638 |
| Oxycodone Hcl | 91 | $1,713 |
| Morphine Sulfate ErMorphine Sulfate | 52 | $1,281 |
| Naloxone Hcl | 20 | $1,227 |
| Gabapentin | 79 | $1,213 |
| Pregabalin | 44 | $1,021 |
| Tramadol Hcl | 85 | $721 |
| Baclofen | 37 | $662 |
| Morphine Sulfate | 22 | $542 |
| Tizanidine Hcl | 55 | $508 |
| Methocarbamol | 29 | $503 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Belbuca, Xtampza Er | $353 | $16,94231 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,166 anesthesiology providers in Arizona.
Other anesthesiology in Tucson
- Steven BarkerTucson$471K
- Kevin EvansTucson$91K
- Randal DullTucson$9K
- Gregory FranklinTucson$7K
- Michael HechtTucson$5K
- Isaac Gomez-AvrahamTucson$4K
- Arnold GeeTucson$4K
- Timothy WardTucson$3K
- Catherynne MorganTucson$3K
- Janelle JambrosicTucson$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.